Please assess the completion status of the following clinical trial:

Trial Title: Comparison Between 7 and 14 Day Primaquine Combined With Dihydroartemisinin-piperaquine or 3 Day Chloroquine Radical Cure of P. Vivax (BPD)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* ≥ 6 months old~* Microscopic diagnosis of Plasmodium vivax malaria mono-infection~* Participant or parent/guardian is willing and able to give informed consent for participation in the study~* Able (in the Investigators opinion) and willing to comply with all study requirements.~Exclusion Criteria:~* Severe malaria~* History of allergy or adverse reaction to artesunate, piperaquine, chloroquine, or primaquine~* Blood transfusion in the past 3 months~* G6PD deficiency by rapid test~* Hematocrit ≤ 25%~* Pregnancy at the time of screening~* Breastfeeding an infant \< 6 months old~* Presence of any condition which in the judgement of the investigator would place the subject at undue risk or interfere with the results of the study

- Gender: ALL
- Minimum Age: 6 Months
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- DHA-P 7 days (Type: EXPERIMENTAL): Dihydroartemisinin-piperaquine + Primaquine: DHA-P 7mg/kg/day dihydroartemisinin and 55mg/kg/day piperaquine daily for 3 days and Primaquine 1 mg/kg once daily for 7 days
- DHA-P 14 days (Type: EXPERIMENTAL): Dihydroartemisinin-piperaquine + Primaquine: DHA-P 7mg/kg/day dihydroartemisinin and 55mg/kg/day piperaquine daily for 3 days Primaquine 0.5 mg/kg daily for 14 days
- Chloroquine 7 days (Type: ACTIVE_COMPARATOR): Chloroquine + Primaquine: Chloroquine 10, 10, 5 and Primaquine 1 mg/kg once daily for 7 days
- Chloroquine 14 days (Type: ACTIVE_COMPARATOR): Chloroquine + Primaquine: Chloroquine 10, 10, 5 and Primaquine 0.5 mg/kg daily for 14 days

Based on this trial design, predict the completion outcome and termination type (if applicable).